Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?

The prevention and control of vector-borne diseases is a priority for improving global health. Despite recent advances in the characterization of ectoparasite-host-pathogen molecular interactions, vaccines are not available for most ectoparasites and vector-borne diseases that cause millions of deat...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Fuente, José, Estrada-Peña, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789832/
https://www.ncbi.nlm.nih.gov/pubmed/31357707
http://dx.doi.org/10.3390/vaccines7030075
_version_ 1783458703479930880
author de la Fuente, José
Estrada-Peña, Agustín
author_facet de la Fuente, José
Estrada-Peña, Agustín
author_sort de la Fuente, José
collection PubMed
description The prevention and control of vector-borne diseases is a priority for improving global health. Despite recent advances in the characterization of ectoparasite-host-pathogen molecular interactions, vaccines are not available for most ectoparasites and vector-borne diseases that cause millions of deaths yearly. In this paper, in response to the question of why new vaccines for the control of ectoparasite vectors have not been registered and commercialized, and to contribute developing new effective vaccines against ectoparasite vectors, we propose challenges and approaches to be addressed.
format Online
Article
Text
id pubmed-6789832
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67898322019-10-16 Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized? de la Fuente, José Estrada-Peña, Agustín Vaccines (Basel) Editorial The prevention and control of vector-borne diseases is a priority for improving global health. Despite recent advances in the characterization of ectoparasite-host-pathogen molecular interactions, vaccines are not available for most ectoparasites and vector-borne diseases that cause millions of deaths yearly. In this paper, in response to the question of why new vaccines for the control of ectoparasite vectors have not been registered and commercialized, and to contribute developing new effective vaccines against ectoparasite vectors, we propose challenges and approaches to be addressed. MDPI 2019-07-28 /pmc/articles/PMC6789832/ /pubmed/31357707 http://dx.doi.org/10.3390/vaccines7030075 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
de la Fuente, José
Estrada-Peña, Agustín
Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title_full Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title_fullStr Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title_full_unstemmed Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title_short Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?
title_sort why new vaccines for the control of ectoparasite vectors have not been registered and commercialized?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789832/
https://www.ncbi.nlm.nih.gov/pubmed/31357707
http://dx.doi.org/10.3390/vaccines7030075
work_keys_str_mv AT delafuentejose whynewvaccinesforthecontrolofectoparasitevectorshavenotbeenregisteredandcommercialized
AT estradapenaagustin whynewvaccinesforthecontrolofectoparasitevectorshavenotbeenregisteredandcommercialized

Ejemplares similares